Agonists |
| Cat No |
Product Name / Activity |
| 3492 |
ACTH (1-39) |
| Potent endogenous MC2 agonist |
| 2566 |
Melanotan II |
| High affinity melanocortin receptor agonist |
| 3424 |
γ1-MSH |
| Selective MC3 receptor agonist |
| 4272 |
[D-Trp8]-γ-MSH |
| Selective MC3 receptor agonist |
| 3013 |
[Nle4,D-Phe7]-α-MSH |
| Melanocortin receptor agonist |
| 2584 |
α-MSH |
| Endogenous melanocortin receptor agonist |
| 5094 |
PG 931 |
| Potent and selective MC4 receptor agonist |
Antagonists |
| Cat No |
Product Name / Activity |
| 1831 |
HS 014 |
| Selective MC4 receptor antagonist |
| 1832 |
HS 024 |
| Highly potent MC4 receptor antagonist |
| 3426 |
JKC 363 |
| Potent and selective MC4 receptor antagonist |
| 3438 |
MCL 0020 |
| Selective MC4 receptor antagonist |
| 5954 |
MSG 606 |
| Potent human MC1 receptor antagonist; also MC3 and MC5 partial agonist |
| 4919 |
PG 106 |
| Selective MC3 receptor antagonist |
Other |
| Cat No |
Product Name / Activity |
| 3611 |
Lys-γ3-MSH |
| Pro-opiomelanocortin (POMC) derived peptide |
| 1929 |
Melanocyte-stimulating hormone release inhibiting factor |
| Inhibitor of α-MSH release; inhibits opioid effects in vivo |
| 3420 |
SHU 9119 |
| MC3 and MC4 antagonist; MC5 partial agonist |